Zometa® Helps Prevent Bone Loss in Early Breast Cancer
August 29, 2008 — Including Zometa® (zoledronic acid) in a treatment regimen for early breast cancer reduces bone loss associated with endocrine therapy among premenopausal women. These results were recently published in the Lancet Oncology.
Genetic Characteristics of Hepatitis B Associated with Risk of Liver Cancer
August 29, 2008 — Different genetic characteristics of the hepatitis B virus (HBV) are associated with varying risks of developing hepatocellular carcinoma (HCC), the most common form of liver cancer. These results were recently published in the Journal of the National Cancer Institute.
Addition of Velcade® to Standard Therapy Improves Survival in Multiple Myeloma
August 29, 2008 — In the treatment of multiple myeloma, the addition of Velcade® (bortezomib) to Alkeran® (melphalan) and prednisone significantly improves progression-free and overall survival compared with Alkeran/prednisone only. These results were recently published in the New England Journal of Medicine.
Select news items provided by Reuters Health